â– PHYSIOLOGICAL CORE: The gastric mucosa is protected from autodigestion by gastric acid (HCl) and pepsin by a physiological mucosal barrier.
â– BARRIER MECHANISMS:
1. Mucus-Bicarbonate Layer: Superficial foveolar cells secrete a thick mucus gel layer containing bicarbonate (HCO3-). This forms a pH gradient (pH ~2 in lumen, pH ~7 at cell surface).
2. Tight Junctions: Epithelial cells are secured by tight junctions, preventing the back-diffusion of protons.
3. Prostaglandin Support: Local prostaglandins (PGE2) stimulate mucus and bicarbonate secretion, inhibit parietal cells, and maintain mucosal blood flow to clear back-diffused protons.
â– IMMUNOLOGICAL & CYTOKINE SIGNALLING FLUX:
Pathogen exposure or cellular distress triggers antigen-presenting cell activation. This results in the release of pro-inflammatory cytokines (such as IL-1, TNF-alpha, and IL-6) and triggers receptor-mediated cellular chemotaxis.
â– PEDIATRIC CONTEXT & CONTINGENCIES:
Developing cohorts present with high body-water percentages and dynamic hepatic enzyme maturation pathways.
[HY-BOARD-1156]
🌟 Dynamic Clinical Key:
Nonsteroidal Anti-inflammatory Drugs (NSAIDs) inhibit Cyclooxygenase-1 (COX-1), blocking prostaglandin synthesis. This compromises mucus and bicarbonate secretion, making the gastric mucosa highly vulnerable to acid damage, potentially leading to gastritis and peptic ulcer disease. Target specific monoclonal antibodies or immune suppressors to control the hyper-inflammatory cascade. Always utilize body-surface-area or weight-based dosing calculators for pediatric populations.